October 24, 2024 - Marietta, PA
Governor Josh Shapiro and GSK leadership announced the global biopharma company's major investment of up to $800 million in Pennsylvania that will increase its research and development (R&D) and manufacturing footprint at its existing facility in Lancaster County. The Commonwealth is supporting this expansion with a $21 million investment, which will create at least 200 new, high-paying jobs. This is the largest Commonwealth-supported economic development project in Lancaster County history. GSK will expand its existing facility at 325 North Bridge Street in Marietta with new facilities to manufacture vaccines and medicines. Currently, one in four Americans are administered a vaccine supplied from the company's Marietta location. This expansion will double the size and capacity of the site. "Pennsylvania is a leader in life sciences - and GSK's decision to make its largest single investment ever in manufacturing in the United States right here in the Commonwealth is further proof that we are the best state in the nation for business growth and economic development," said Governor Shapiro. "Our Commonwealth offers the skilled workforce, market access, and innovation infrastructure that biotech and life sciences companies need to thrive. Pennsylvania is getting things done, and my Administration will continue to work with companies like GSK to drive innovation forward and create jobs - and economic opportunity - for people across the Commonwealth." List of Speakers:Matteo LeardiniGovernor ShapiroMaya Martinez-Davis, President, U.S. GSKSecretary Rick Siger
An Official Pennsylvania Government Website